Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Prana Alzheimer’s drug demonstrates safety in trial
Data from the study showed PBT2 was well tolerated with little difference in the incidence of adverse events between those receiving PBT2 and those receiving the placebo. In
Data from the study showed PBT2 was well tolerated with little difference in the incidence of adverse events between those receiving PBT2 and those receiving the placebo. In
The study is part of a broad phase II development program of ISIS 301012, a second-generation antisense drug. ISIS 301012 selectively reduces apoB-100, a target critical to the
The first such product that Cobra will develop will be Lovaxin C, Advaxis’ therapeutic vaccine for the treatment of cervical and head and neck cancers that will be
The study will evaluate the safety and efficacy of Davanat with 5-Fluorouracil (5-FU) in combination with irinotecan or oxaliplatin for second line treatment of patients with metastatic colorectal
Revatio contains the same active ingredient as Viagra, the company’s erectile dysfunction medication, which has been used by more than 27 million men worldwide. Pulmonary arterial hypertension (PAH)
The generic version is named lamivudine and is manufactured by Aurobindo Pharma of India. According to the FDA, the copycat product will now be available for consideration for
Under the terms of the company’s license agreement with Bayer AG, the company is obligated to make a $1 million milestone payment to Bayer as a result of
BRAF is a protein that plays a central role in the growth and survival of cancer cells and is mutated in the majority of patients with melanoma and
In this study, conducted by researchers at Johns Hopkins University and Dartmouth Medical School, rats were treated with RTA403 and exposed to a potent natural carcinogen known as
MLN8054, an orally administered small molecule, was discovered and is being developed by Millennium scientists. This first clinical study will assess safety, determine the maximum tolerated dose, and